Lyra Therapeutics Statistics
Total Valuation
LYRA has a market cap or net worth of $11.65 million. The enterprise value is $13.48 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LYRA has 1.60 million shares outstanding. The number of shares has increased by 6.46% in one year.
| Current Share Class | 1.60M |
| Shares Outstanding | 1.60M |
| Shares Change (YoY) | +6.46% |
| Shares Change (QoQ) | +2.55% |
| Owned by Insiders (%) | 1.43% |
| Owned by Institutions (%) | 25.87% |
| Float | 1.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.58 |
| Forward PS | 17.19 |
| PB Ratio | 6.76 |
| P/TBV Ratio | 6.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.78, with a Debt / Equity ratio of 20.02.
| Current Ratio | 2.78 |
| Quick Ratio | 2.67 |
| Debt / Equity | 20.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -238.26% and return on invested capital (ROIC) is -43.93%.
| Return on Equity (ROE) | -238.26% |
| Return on Assets (ROA) | -30.40% |
| Return on Invested Capital (ROIC) | -43.93% |
| Return on Capital Employed (ROCE) | -86.42% |
| Revenue Per Employee | $25,667 |
| Profits Per Employee | -$1.29M |
| Employee Count | 30 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LYRA has paid $19,000 in taxes.
| Income Tax | 19,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.36% in the last 52 weeks. The beta is 0.16, so LYRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -50.36% |
| 50-Day Moving Average | 10.54 |
| 200-Day Moving Average | 9.12 |
| Relative Strength Index (RSI) | 46.82 |
| Average Volume (20 Days) | 31,429 |
Short Selling Information
The latest short interest is 45,614, so 2.85% of the outstanding shares have been sold short.
| Short Interest | 45,614 |
| Short Previous Month | 49,858 |
| Short % of Shares Out | 2.85% |
| Short % of Float | 3.79% |
| Short Ratio (days to cover) | 0.85 |
Income Statement
In the last 12 months, LYRA had revenue of $770,000 and -$38.84 million in losses. Loss per share was -$29.40.
| Revenue | 770,000 |
| Gross Profit | -43.00M |
| Operating Income | -35.79M |
| Pretax Income | -68.82M |
| Net Income | -38.84M |
| EBITDA | -35.34M |
| EBIT | -35.79M |
| Loss Per Share | -$29.40 |
Full Income StatementBalance Sheet
The company has $29.78 million in cash and $32.48 million in debt, giving a net cash position of -$2.69 million or -$1.69 per share.
| Cash & Cash Equivalents | 29.78M |
| Total Debt | 32.48M |
| Net Cash | -2.69M |
| Net Cash Per Share | -$1.69 |
| Equity (Book Value) | 1.62M |
| Book Value Per Share | 1.00 |
| Working Capital | 19.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$43.01 million and capital expenditures -$13,000, giving a free cash flow of -$43.02 million.
| Operating Cash Flow | -43.01M |
| Capital Expenditures | -13,000 |
| Free Cash Flow | -43.02M |
| FCF Per Share | -$26.91 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -4,647.79% |
| Pretax Margin | -5,041.17% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LYRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.46% |
| Shareholder Yield | -6.46% |
| Earnings Yield | -359.96% |
| FCF Yield | -398.74% |
Analyst Forecast
The average price target for LYRA is $16.00, which is 119.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $16.00 |
| Price Target Difference | 119.48% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 123.35% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 28, 2025. It was a reverse split with a ratio of 1:50.
| Last Split Date | May 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |